AR033260A1 - Nueva composicion hormonal y su utilizacion - Google Patents
Nueva composicion hormonal y su utilizacionInfo
- Publication number
- AR033260A1 AR033260A1 ARP020101475A ARP020101475A AR033260A1 AR 033260 A1 AR033260 A1 AR 033260A1 AR P020101475 A ARP020101475 A AR P020101475A AR P020101475 A ARP020101475 A AR P020101475A AR 033260 A1 AR033260 A1 AR 033260A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- estrogenic
- association
- new
- stroprogestative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
Dominio de la química terapéutica, y más particularmente dominio de la técnica farmacéutica hormonal. Nuevas composiciones farmacéuticas hormonales formadas por una asociacion estroprogestativa constituida por un compuesto estrogeno y un compuesto progestativo, en asociacion o mezclado con varios excipientes no toxicos, inertes, farmacéuticamente aceptables, destinadas a la administracion por vía bucal.Uso de una mezcla estroprogestativa en que el compuesto estrogénico y el compuesto progestativo se administran de una manera combinada la asociacion combinada puede ser prescripta de una manera continua o intermitente mediante la preparacion de un compuesto destinado al tratamiento de carencias estrogénicas, evitar la osteoporosis y las enfermedades, en la mujer menopáusica. Un procedimiento para la preparacion de estas nuevas composiciones farmacéuticas estroprogestativas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0105557A FR2823976A1 (fr) | 2001-04-25 | 2001-04-25 | Nouvelle composition hormonale et son utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR033260A1 true AR033260A1 (es) | 2003-12-10 |
Family
ID=8862668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020101475A AR033260A1 (es) | 2001-04-25 | 2002-04-24 | Nueva composicion hormonal y su utilizacion |
Country Status (9)
| Country | Link |
|---|---|
| KR (1) | KR20030043797A (es) |
| CN (1) | CN1464787A (es) |
| AR (1) | AR033260A1 (es) |
| AU (1) | AU2002310721A1 (es) |
| BR (1) | BR0205104A (es) |
| FR (1) | FR2823976A1 (es) |
| MA (1) | MA26833A1 (es) |
| NO (1) | NO20026215L (es) |
| WO (1) | WO2002085375A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200500315A (es) * | 2004-11-02 | 2006-06-06 | Formas de dosificacion oral solidas que contienen una dosis baja de estradiol | |
| US8022053B2 (en) | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
| FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
-
2001
- 2001-04-25 FR FR0105557A patent/FR2823976A1/fr not_active Withdrawn
-
2002
- 2002-04-15 MA MA26603A patent/MA26833A1/fr unknown
- 2002-04-23 CN CN02802212A patent/CN1464787A/zh active Pending
- 2002-04-23 KR KR1020027017624A patent/KR20030043797A/ko not_active Application Discontinuation
- 2002-04-23 WO PCT/FR2002/001384 patent/WO2002085375A1/fr not_active Application Discontinuation
- 2002-04-23 AU AU2002310721A patent/AU2002310721A1/en not_active Abandoned
- 2002-04-23 BR BR0205104-4A patent/BR0205104A/pt not_active Application Discontinuation
- 2002-04-24 AR ARP020101475A patent/AR033260A1/es not_active Application Discontinuation
- 2002-12-23 NO NO20026215A patent/NO20026215L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030043797A (ko) | 2003-06-02 |
| MA26833A1 (fr) | 2004-12-20 |
| FR2823976A1 (fr) | 2002-10-31 |
| CN1464787A (zh) | 2003-12-31 |
| BR0205104A (pt) | 2003-05-20 |
| NO20026215D0 (no) | 2002-12-23 |
| AU2002310721A1 (en) | 2002-11-05 |
| NO20026215L (no) | 2003-02-21 |
| WO2002085375A8 (fr) | 2003-02-20 |
| WO2002085375A1 (fr) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| AR031563A1 (es) | Una composicion farmaceutica para emplear en el tratamiento de trastornos menopausicos o posmenopausicos de estrogenos y acetato de medroxiprogesterona, una unidad de dosificacion farmaceutica y uso de una combinacion de estrogenos conjugados y acetato de medroxiprogesterona para la manufactura de u | |
| EA200301022A1 (ru) | Гормональная заместительная терапия | |
| EA200600964A1 (ru) | Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина | |
| EA200600029A1 (ru) | Фармацевтическая композиция для контрацепции и заместительной гормональной терапии | |
| BRPI0412493A (pt) | métodos de tratamento hormonal utilizando regimes contraceptivos com administração contìnua de estrogênio | |
| HUP0102913A2 (hu) | Biogén ösztrogén-szulfamátok alkalmazása hormonhelyettesítő terápiánál használható gyógyszerkészítmények előállítására | |
| AP1849A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
| AP1625A (en) | Hormonal composition based on a progesterone and an oestrogen and use thereof. | |
| HUP0301460A2 (hu) | Antiprogresztinek használata hormonfüggő betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállításához | |
| AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
| MY128482A (en) | New hormonal composition and its use | |
| AR065816A1 (es) | Regimen anticonceptivo oral | |
| HUP0500346A2 (hu) | Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására | |
| ES2303811T1 (es) | Uso de anastrozol para el tratamiento post-menopausico de una mujer que tiene cancer de mama temprano. | |
| AR033260A1 (es) | Nueva composicion hormonal y su utilizacion | |
| CR6627A (es) | Nuevo medicamento contraceptivo y su modo de preparacion | |
| HUP0004461A2 (hu) | Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények | |
| AR039228A1 (es) | Terapia de reemplazo hormonal | |
| AR039227A1 (es) | Terapia de reemplazo hormonal | |
| JP2005532336A5 (es) | ||
| AR039477A1 (es) | Terapia de reemplazo hormonal | |
| CR6628A (es) | Nueva composicion hormonal y su utilizacion | |
| EP1857110A3 (en) | Hormone replacement therapy | |
| HRP20020666B1 (en) | Drospirenone for hormone replacement therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |